Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 27916969 | HLA-DRB1 (HLA-DRB1) | lyme borreliosis | Latvian | NA | NA | unclassified | |
| the aim of this study was to determine the human leukocyte antigen (hla)-drb1 alleles in two groups of patients in latvia: patients with lyme borreliosis and patients with lyme neuroborreliosis. | |||||||
| 27916969 | HLA-DRB1 (HLA-DRB1) | lyme neuroborreliosis | Latvian | NA | NA | unclassified | |
| the aim of this study was to determine the human leukocyte antigen (hla)-drb1 alleles in two groups of patients in latvia: patients with lyme borreliosis and patients with lyme neuroborreliosis. | |||||||
| 27916969 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lyme borreliosis | Latvian | NA | NA | unclassified | |
| the aim of this study was to determine the human leukocyte antigen (hla)-drb1 alleles in two groups of patients in latvia: patients with lyme borreliosis and patients with lyme neuroborreliosis. | |||||||
| 27916969 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lyme neuroborreliosis | Latvian | NA | NA | unclassified | |
| the aim of this study was to determine the human leukocyte antigen (hla)-drb1 alleles in two groups of patients in latvia: patients with lyme borreliosis and patients with lyme neuroborreliosis. | |||||||
| 27916969 | HLA-DRB1*07 | lyme borreliosis | Latvian | NA | NA | unclassified | |
| the predisposition to the lyme borreliosis is associated with the hla-drb1*07, -drb1*17(03), -drb1*04, -drb1*15(02) alleles. | |||||||
| 27916969 | HLA-DRB1*04 | lyme borreliosis | Latvian | NA | NA | unclassified | |
| the predisposition to the lyme borreliosis is associated with the hla-drb1*07, -drb1*17(03), -drb1*04, -drb1*15(02) alleles. | |||||||
| 27916969 | HLA-DRB1*15 | lyme borreliosis | Latvian | NA | NA | unclassified | |
| the predisposition to the lyme borreliosis is associated with the hla-drb1*07, -drb1*17(03), -drb1*04, -drb1*15(02) alleles. | |||||||
| 27916969 | HLA-DRB1*07 | lyme neuroborreliosis | Latvian | NA | NA | positive | |
| in-group with lyme neuroborreliosis differences were found for the -drb1*07 and -drb1*04 alleles, but only hla-drb1*07 allele was statistically significant after bonferroni correction and associated with lyme neuroborreliosis in latvian patients. | |||||||
| 27916969 | HLA-DRB1*04 | lyme neuroborreliosis | Latvian | NA | NA | positive | |
| in-group with lyme neuroborreliosis differences were found for the -drb1*07 and -drb1*04 alleles, but only hla-drb1*07 allele was statistically significant after bonferroni correction and associated with lyme neuroborreliosis in latvian patients. | |||||||
| 30568303 | HLA-A*24 | glioblastomas | NA | NA | NA | unclassified | |
| fifteen patients with glioblastomas positive for human leukocyte antigen (hla)-a*02:01 or hla-a*24:02 were treated with a vaccine (apvac1) derived from a premanufactured library of unmutated antigens followed by treatment with apvac2, which preferentially targeted neoepitopes. | |||||||
Copyright 2024